According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Hematopoietic Stem Cells (HSCs) Market

The global market for Hematopoietic Stem Cells (HSCs) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Hematopoietic Stem Cells (HSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematopoietic Stem Cells (HSCs).

The Hematopoietic Stem Cells (HSCs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hematopoietic Stem Cells (HSCs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hematopoietic Stem Cells (HSCs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hematopoietic Stem Cells (HSCs) Market Report

Report Metric	Details
Report Name	Hematopoietic Stem Cells (HSCs) Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Leukocyte Lymphocytes Red Blood Cells Platelets
Segment by Application	Blood System Diseases Autoimmune Diseases Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH, Cesca Therapeutics Inc., R&D Systems, Genlantis, Lonza Group Ltd., TiGenix N.V., ScienCell Research Laboratories, China Cord Blood Corporation, Vcanbio, Boyalife, Beike Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematopoietic Stem Cells (HSCs) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hematopoietic Stem Cells (HSCs) Market report?

Ans: The main players in the Hematopoietic Stem Cells (HSCs) Market are Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH, Cesca Therapeutics Inc., R&D Systems, Genlantis, Lonza Group Ltd., TiGenix N.V., ScienCell Research Laboratories, China Cord Blood Corporation, Vcanbio, Boyalife, Beike Biotechnology

What are the Application segmentation covered in the Hematopoietic Stem Cells (HSCs) Market report?

Ans: The Applications covered in the Hematopoietic Stem Cells (HSCs) Market report are Blood System Diseases, Autoimmune Diseases, Other

What are the Type segmentation covered in the Hematopoietic Stem Cells (HSCs) Market report?

Ans: The Types covered in the Hematopoietic Stem Cells (HSCs) Market report are Leukocyte, Lymphocytes, Red Blood Cells, Platelets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Leukocyte

1.2.3 Lymphocytes

1.2.4 Red Blood Cells

1.2.5 Platelets

1.3 Market by Application

1.3.1 Global Hematopoietic Stem Cells (HSCs) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Blood System Diseases

1.3.3 Autoimmune Diseases

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hematopoietic Stem Cells (HSCs) Market Perspective (2020-2031)

2.2 Global Hematopoietic Stem Cells (HSCs) Growth Trends by Region

2.2.1 Global Hematopoietic Stem Cells (HSCs) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Hematopoietic Stem Cells (HSCs) Historic Market Size by Region (2020-2025)

2.2.3 Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Region (2026-2031)

2.3 Hematopoietic Stem Cells (HSCs) Market Dynamics

2.3.1 Hematopoietic Stem Cells (HSCs) Industry Trends

2.3.2 Hematopoietic Stem Cells (HSCs) Market Drivers

2.3.3 Hematopoietic Stem Cells (HSCs) Market Challenges

2.3.4 Hematopoietic Stem Cells (HSCs) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Hematopoietic Stem Cells (HSCs) Players by Revenue

3.1.1 Global Top Hematopoietic Stem Cells (HSCs) Players by Revenue (2020-2025)

3.1.2 Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Players (2020-2025)

3.2 Global Hematopoietic Stem Cells (HSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Hematopoietic Stem Cells (HSCs) Revenue

3.4 Global Hematopoietic Stem Cells (HSCs) Market Concentration Ratio

3.4.1 Global Hematopoietic Stem Cells (HSCs) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hematopoietic Stem Cells (HSCs) Revenue in 2024

3.5 Global Key Players of Hematopoietic Stem Cells (HSCs) Head office and Area Served

3.6 Global Key Players of Hematopoietic Stem Cells (HSCs), Product and Application

3.7 Global Key Players of Hematopoietic Stem Cells (HSCs), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Hematopoietic Stem Cells (HSCs) Breakdown Data by Type

4.1 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Type (2020-2025)

4.2 Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Type (2026-2031)

5 Hematopoietic Stem Cells (HSCs) Breakdown Data by Application

5.1 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Application (2020-2025)

5.2 Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Hematopoietic Stem Cells (HSCs) Market Size (2020-2031)

6.2 North America Hematopoietic Stem Cells (HSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2020-2025)

6.4 North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Hematopoietic Stem Cells (HSCs) Market Size (2020-2031)

7.2 Europe Hematopoietic Stem Cells (HSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2020-2025)

7.4 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size (2020-2031)

8.2 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2020-2025)

8.4 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Hematopoietic Stem Cells (HSCs) Market Size (2020-2031)

9.2 Latin America Hematopoietic Stem Cells (HSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2020-2025)

9.4 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size (2020-2031)

10.2 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2020-2025)

10.4 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Kite Pharma Inc.

11.1.1 Kite Pharma Inc. Company Details

11.1.2 Kite Pharma Inc. Business Overview

11.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Introduction

11.1.4 Kite Pharma Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

11.1.5 Kite Pharma Inc. Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Introduction

11.2.4 Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 PromoCell

11.3.1 PromoCell Company Details

11.3.2 PromoCell Business Overview

11.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Introduction

11.3.4 PromoCell Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

11.3.5 PromoCell Recent Development

11.4 CellGenix Technologie Transfer GmbH

11.4.1 CellGenix Technologie Transfer GmbH Company Details

11.4.2 CellGenix Technologie Transfer GmbH Business Overview

11.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Introduction

11.4.4 CellGenix Technologie Transfer GmbH Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

11.4.5 CellGenix Technologie Transfer GmbH Recent Development

11.5 Cesca Therapeutics Inc.

11.5.1 Cesca Therapeutics Inc. Company Details

11.5.2 Cesca Therapeutics Inc. Business Overview

11.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Introduction

11.5.4 Cesca Therapeutics Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

11.5.5 Cesca Therapeutics Inc. Recent Development

11.6 R&D Systems

11.6.1 R&D Systems Company Details

11.6.2 R&D Systems Business Overview

11.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Introduction

11.6.4 R&D Systems Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

11.6.5 R&D Systems Recent Development

11.7 Genlantis

11.7.1 Genlantis Company Details

11.7.2 Genlantis Business Overview

11.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Introduction

11.7.4 Genlantis Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

11.7.5 Genlantis Recent Development

11.8 Lonza Group Ltd.

11.8.1 Lonza Group Ltd. Company Details

11.8.2 Lonza Group Ltd. Business Overview

11.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Introduction

11.8.4 Lonza Group Ltd. Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

11.8.5 Lonza Group Ltd. Recent Development

11.9 TiGenix N.V.

11.9.1 TiGenix N.V. Company Details

11.9.2 TiGenix N.V. Business Overview

11.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Introduction

11.9.4 TiGenix N.V. Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

11.9.5 TiGenix N.V. Recent Development

11.10 ScienCell Research Laboratories

11.10.1 ScienCell Research Laboratories Company Details

11.10.2 ScienCell Research Laboratories Business Overview

11.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Introduction

11.10.4 ScienCell Research Laboratories Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

11.10.5 ScienCell Research Laboratories Recent Development

11.11 China Cord Blood Corporation

11.11.1 China Cord Blood Corporation Company Details

11.11.2 China Cord Blood Corporation Business Overview

11.11.3 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Introduction

11.11.4 China Cord Blood Corporation Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

11.11.5 China Cord Blood Corporation Recent Development

11.12 Vcanbio

11.12.1 Vcanbio Company Details

11.12.2 Vcanbio Business Overview

11.12.3 Vcanbio Hematopoietic Stem Cells (HSCs) Introduction

11.12.4 Vcanbio Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

11.12.5 Vcanbio Recent Development

11.13 Boyalife

11.13.1 Boyalife Company Details

11.13.2 Boyalife Business Overview

11.13.3 Boyalife Hematopoietic Stem Cells (HSCs) Introduction

11.13.4 Boyalife Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

11.13.5 Boyalife Recent Development

11.14 Beike Biotechnology

11.14.1 Beike Biotechnology Company Details

11.14.2 Beike Biotechnology Business Overview

11.14.3 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Introduction

11.14.4 Beike Biotechnology Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

11.14.5 Beike Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Kite Pharma Inc.

Thermo Fisher Scientific

PromoCell

CellGenix Technologie Transfer GmbH

Cesca Therapeutics Inc.

ScienCell Research Laboratories

China Cord Blood Corporation

Vcanbio

Boyalife

Beike Biotechnology

List of Tables

Table 1. Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Leukocyte

Table 3. Key Players of Lymphocytes

Table 4. Key Players of Red Blood Cells

Table 5. Key Players of Platelets

Table 6. Global Hematopoietic Stem Cells (HSCs) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Hematopoietic Stem Cells (HSCs) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Hematopoietic Stem Cells (HSCs) Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Hematopoietic Stem Cells (HSCs) Market Share by Region (2020-2025)

Table 10. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Hematopoietic Stem Cells (HSCs) Market Share by Region (2026-2031)

Table 12. Hematopoietic Stem Cells (HSCs) Market Trends

Table 13. Hematopoietic Stem Cells (HSCs) Market Drivers

Table 14. Hematopoietic Stem Cells (HSCs) Market Challenges

Table 15. Hematopoietic Stem Cells (HSCs) Market Restraints

Table 16. Global Hematopoietic Stem Cells (HSCs) Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Hematopoietic Stem Cells (HSCs) Market Share by Players (2020-2025)

Table 18. Global Top Hematopoietic Stem Cells (HSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2024)

Table 19. Ranking of Global Top Hematopoietic Stem Cells (HSCs) Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Hematopoietic Stem Cells (HSCs) Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Hematopoietic Stem Cells (HSCs), Headquarters and Area Served

Table 22. Global Key Players of Hematopoietic Stem Cells (HSCs), Product and Application

Table 23. Global Key Players of Hematopoietic Stem Cells (HSCs), Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Hematopoietic Stem Cells (HSCs) Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type (2020-2025)

Table 27. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type (2026-2031)

Table 29. Global Hematopoietic Stem Cells (HSCs) Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Application (2020-2025)

Table 31. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Application (2026-2031)

Table 33. North America Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2026-2031) & (US$ Million)

Table 48. Kite Pharma Inc. Company Details

Table 49. Kite Pharma Inc. Business Overview

Table 50. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Product

Table 51. Kite Pharma Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025) & (US$ Million)

Table 52. Kite Pharma Inc. Recent Development

Table 53. Thermo Fisher Scientific Company Details

Table 54. Thermo Fisher Scientific Business Overview

Table 55. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Product

Table 56. Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025) & (US$ Million)

Table 57. Thermo Fisher Scientific Recent Development

Table 58. PromoCell Company Details

Table 59. PromoCell Business Overview

Table 60. PromoCell Hematopoietic Stem Cells (HSCs) Product

Table 61. PromoCell Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025) & (US$ Million)

Table 62. PromoCell Recent Development

Table 63. CellGenix Technologie Transfer GmbH Company Details

Table 64. CellGenix Technologie Transfer GmbH Business Overview

Table 65. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Product

Table 66. CellGenix Technologie Transfer GmbH Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025) & (US$ Million)

Table 67. CellGenix Technologie Transfer GmbH Recent Development

Table 68. Cesca Therapeutics Inc. Company Details

Table 69. Cesca Therapeutics Inc. Business Overview

Table 70. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Product

Table 71. Cesca Therapeutics Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025) & (US$ Million)

Table 72. Cesca Therapeutics Inc. Recent Development

Table 73. R&D Systems Company Details

Table 74. R&D Systems Business Overview

Table 75. R&D Systems Hematopoietic Stem Cells (HSCs) Product

Table 76. R&D Systems Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025) & (US$ Million)

Table 77. R&D Systems Recent Development

Table 78. Genlantis Company Details

Table 79. Genlantis Business Overview

Table 80. Genlantis Hematopoietic Stem Cells (HSCs) Product

Table 81. Genlantis Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025) & (US$ Million)

Table 82. Genlantis Recent Development

Table 83. Lonza Group Ltd. Company Details

Table 84. Lonza Group Ltd. Business Overview

Table 85. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Product

Table 86. Lonza Group Ltd. Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025) & (US$ Million)

Table 87. Lonza Group Ltd. Recent Development

Table 88. TiGenix N.V. Company Details

Table 89. TiGenix N.V. Business Overview

Table 90. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Product

Table 91. TiGenix N.V. Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025) & (US$ Million)

Table 92. TiGenix N.V. Recent Development

Table 93. ScienCell Research Laboratories Company Details

Table 94. ScienCell Research Laboratories Business Overview

Table 95. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Product

Table 96. ScienCell Research Laboratories Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025) & (US$ Million)

Table 97. ScienCell Research Laboratories Recent Development

Table 98. China Cord Blood Corporation Company Details

Table 99. China Cord Blood Corporation Business Overview

Table 100. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Product

Table 101. China Cord Blood Corporation Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025) & (US$ Million)

Table 102. China Cord Blood Corporation Recent Development

Table 103. Vcanbio Company Details

Table 104. Vcanbio Business Overview

Table 105. Vcanbio Hematopoietic Stem Cells (HSCs) Product

Table 106. Vcanbio Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025) & (US$ Million)

Table 107. Vcanbio Recent Development

Table 108. Boyalife Company Details

Table 109. Boyalife Business Overview

Table 110. Boyalife Hematopoietic Stem Cells (HSCs) Product

Table 111. Boyalife Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025) & (US$ Million)

Table 112. Boyalife Recent Development

Table 113. Beike Biotechnology Company Details

Table 114. Beike Biotechnology Business Overview

Table 115. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Product

Table 116. Beike Biotechnology Revenue in Hematopoietic Stem Cells (HSCs) Business (2020-2025) & (US$ Million)

Table 117. Beike Biotechnology Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Hematopoietic Stem Cells (HSCs) Picture

Figure 2. Global Hematopoietic Stem Cells (HSCs) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Hematopoietic Stem Cells (HSCs) Market Share by Type: 2024 VS 2031

Figure 4. Leukocyte Features

Figure 5. Lymphocytes Features

Figure 6. Red Blood Cells Features

Figure 7. Platelets Features

Figure 8. Global Hematopoietic Stem Cells (HSCs) Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Hematopoietic Stem Cells (HSCs) Market Share by Application: 2024 VS 2031

Figure 10. Blood System Diseases Case Studies

Figure 11. Autoimmune Diseases Case Studies

Figure 12. Other Case Studies

Figure 13. Hematopoietic Stem Cells (HSCs) Report Years Considered

Figure 14. Global Hematopoietic Stem Cells (HSCs) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Hematopoietic Stem Cells (HSCs) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Hematopoietic Stem Cells (HSCs) Market Share by Region: 2024 VS 2031

Figure 17. Global Hematopoietic Stem Cells (HSCs) Market Share by Players in 2024

Figure 18. Global Top Hematopoietic Stem Cells (HSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Hematopoietic Stem Cells (HSCs) Revenue in 2024

Figure 20. North America Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Hematopoietic Stem Cells (HSCs) Market Share by Country (2020-2031)

Figure 22. United States Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Hematopoietic Stem Cells (HSCs) Market Share by Country (2020-2031)

Figure 26. Germany Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Share by Region (2020-2031)

Figure 34. China Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Hematopoietic Stem Cells (HSCs) Market Share by Country (2020-2031)

Figure 42. Mexico Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Share by Country (2020-2031)

Figure 46. Turkey Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Kite Pharma Inc. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

Figure 51. PromoCell Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

Figure 52. CellGenix Technologie Transfer GmbH Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

Figure 53. Cesca Therapeutics Inc. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

Figure 54. R&D Systems Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

Figure 55. Genlantis Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

Figure 56. Lonza Group Ltd. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

Figure 57. TiGenix N.V. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

Figure 58. ScienCell Research Laboratories Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

Figure 59. China Cord Blood Corporation Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

Figure 60. Vcanbio Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

Figure 61. Boyalife Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

Figure 62. Beike Biotechnology Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions